dr david

EOS imaging obtains FDA approval for hipEOS, the first 3D stereoradiographic planning software for hip arthroplasty

EOS imaging obtains FDA approval for hipEOS, the first 3D stereoradiographic planning software for hip arthroplasty
EOS imaging, the pioneer in orthopaedic 2D/3D imaging, announced today that the U.S. Food and Drug Administration has approved hipEOS, a 3D hip arthroplasty planning software […]

EOS imaging, the pioneer in orthopaedic 2D/3D imaging, announced today that the U.S. Food and Drug Administration has approved hipEOS, a 3D hip arthroplasty planning software based on EOS stereo-radiographic 2D/3D imaging. hipEOS is the first offering of a software portfolio associated with the EOS imaging system. Developed by OneFit medical, an EOS imaging group company, the software enables surgeons to perform, using EOS unique stereo-radiographic 2D/3D low dose images, pre-surgical planning including hip implant selection and virtual positioning in functional, weight-bearing 3D. The software takes full advantage of the bias-free, real size 3D patient anatomical information obtained from the EOS exam to help physicians define implant size and visualize pre-operatively the restoration expected from a total hip arthroplasty prior to surgery. hipEOS received a CE Mark in March 2014.

Read more

aahks aaos abos oawf vcu

X

Tell a Friend